Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990330706> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W1990330706 endingPage "543" @default.
- W1990330706 startingPage "538" @default.
- W1990330706 abstract "Abstract The enzyme which forms glucocerebroside, ceramide: UDP‐glucose glucosyltransferase, is inactivated in vitro by a cationic analog of cerebroside, 2‐decanoylamino‐3‐morpholinopropiophenone. A study of the inhibitor using intraperitoneal injection into young mice showed that the level of the enzyme activity in liver was appreciably lowered between 3 and 6 hr after injection. The activity increased subsequently, overshooting the normal level within 24 hr by about 20%, then returning to normal within the next 24 hr. Additional effects observed in liver were an increase in lipid content (primarily in the triglyceride fraction and ceramides) and a decrease in the glucocerebroside level. Body temperature dropped rapidly. Markedly similar effects were produced by injecting chlorpromazine, which was tried in order to reduce the hyperirritability and inhibitory effects on monoamine oxidase previously demonstrated by the glucosyltransferase inhibitor. Chlorpromazine did indeed block the hyperirritability and resulted in enhancement of the keto amine's effects on the enzyme and lipids. It is possible that the two drugs in combination would be helpful in ameliorating the symptoms due to the cerebroside accumulation that occurs in Gaucher disease. Diazepam also produced a reduced level of glucosyltransferase. A color reaction for chlorpromazine, possibly suitable for quantitative determination in tissues, was accidentally discovered." @default.
- W1990330706 created "2016-06-24" @default.
- W1990330706 creator A5036583678 @default.
- W1990330706 creator A5061360317 @default.
- W1990330706 creator A5085646904 @default.
- W1990330706 date "1982-08-01" @default.
- W1990330706 modified "2023-09-29" @default.
- W1990330706 title "Changes in liver lipids after administration of 2-decanoylamino-3-morpholinopropiophenone and chlorpromazine" @default.
- W1990330706 cites W1470342350 @default.
- W1990330706 cites W1483635415 @default.
- W1990330706 cites W1549255782 @default.
- W1990330706 cites W2020552217 @default.
- W1990330706 cites W2034539046 @default.
- W1990330706 cites W2036128094 @default.
- W1990330706 cites W2047157824 @default.
- W1990330706 cites W2048561509 @default.
- W1990330706 cites W2054433044 @default.
- W1990330706 cites W2054860711 @default.
- W1990330706 cites W2069946484 @default.
- W1990330706 cites W2076372283 @default.
- W1990330706 cites W2116844182 @default.
- W1990330706 cites W2126902262 @default.
- W1990330706 cites W4254160347 @default.
- W1990330706 cites W5275200 @default.
- W1990330706 doi "https://doi.org/10.1007/bf02535381" @default.
- W1990330706 hasPublicationYear "1982" @default.
- W1990330706 type Work @default.
- W1990330706 sameAs 1990330706 @default.
- W1990330706 citedByCount "14" @default.
- W1990330706 countsByYear W19903307062017 @default.
- W1990330706 crossrefType "journal-article" @default.
- W1990330706 hasAuthorship W1990330706A5036583678 @default.
- W1990330706 hasAuthorship W1990330706A5061360317 @default.
- W1990330706 hasAuthorship W1990330706A5085646904 @default.
- W1990330706 hasBestOaLocation W19903307062 @default.
- W1990330706 hasConcept C126322002 @default.
- W1990330706 hasConcept C134018914 @default.
- W1990330706 hasConcept C181199279 @default.
- W1990330706 hasConcept C185592680 @default.
- W1990330706 hasConcept C2775872319 @default.
- W1990330706 hasConcept C2776024655 @default.
- W1990330706 hasConcept C2777858569 @default.
- W1990330706 hasConcept C2778775820 @default.
- W1990330706 hasConcept C2779994418 @default.
- W1990330706 hasConcept C2780674200 @default.
- W1990330706 hasConcept C28212737 @default.
- W1990330706 hasConcept C55493867 @default.
- W1990330706 hasConcept C71924100 @default.
- W1990330706 hasConcept C98274493 @default.
- W1990330706 hasConceptScore W1990330706C126322002 @default.
- W1990330706 hasConceptScore W1990330706C134018914 @default.
- W1990330706 hasConceptScore W1990330706C181199279 @default.
- W1990330706 hasConceptScore W1990330706C185592680 @default.
- W1990330706 hasConceptScore W1990330706C2775872319 @default.
- W1990330706 hasConceptScore W1990330706C2776024655 @default.
- W1990330706 hasConceptScore W1990330706C2777858569 @default.
- W1990330706 hasConceptScore W1990330706C2778775820 @default.
- W1990330706 hasConceptScore W1990330706C2779994418 @default.
- W1990330706 hasConceptScore W1990330706C2780674200 @default.
- W1990330706 hasConceptScore W1990330706C28212737 @default.
- W1990330706 hasConceptScore W1990330706C55493867 @default.
- W1990330706 hasConceptScore W1990330706C71924100 @default.
- W1990330706 hasConceptScore W1990330706C98274493 @default.
- W1990330706 hasIssue "8" @default.
- W1990330706 hasLocation W19903307061 @default.
- W1990330706 hasLocation W19903307062 @default.
- W1990330706 hasOpenAccess W1990330706 @default.
- W1990330706 hasPrimaryLocation W19903307061 @default.
- W1990330706 hasRelatedWork W1990330706 @default.
- W1990330706 hasRelatedWork W2010372900 @default.
- W1990330706 hasRelatedWork W2021681271 @default.
- W1990330706 hasRelatedWork W2041286807 @default.
- W1990330706 hasRelatedWork W2043193575 @default.
- W1990330706 hasRelatedWork W2043709216 @default.
- W1990330706 hasRelatedWork W2044389122 @default.
- W1990330706 hasRelatedWork W2154655378 @default.
- W1990330706 hasRelatedWork W2163066854 @default.
- W1990330706 hasRelatedWork W2386230476 @default.
- W1990330706 hasVolume "17" @default.
- W1990330706 isParatext "false" @default.
- W1990330706 isRetracted "false" @default.
- W1990330706 magId "1990330706" @default.
- W1990330706 workType "article" @default.